Severe Acute Respiratory Syndrome (SARS)
Severe Acute Respiratory Syndrome is extreme intense respiratory disorder (SARS) is a viral respiratory infection brought about by a SARS-related Covid. It was first recognized toward the finish of February 2003 during a flare-up that arose in China and spread to 4 different nations. WHO coordinated the worldwide examination with the help of the Global Outbreak Alert and Response Network (GOARN) and worked intimately with wellbeing experts in influenced nations to give epidemiological, clinical and calculated help and to manage the flare-up. SARS is an airborne infection and can spread through little beads of spit along these lines to the cold and flu. It was the primary extreme and promptly contagious new illness to arise in the 21st century and showed a reasonable ability to spread along the courses of global air travel. SARS can likewise be spread by implication through surfaces that have been moved by somebody who is contaminated with the infection.
- Fever of 100.5 F (38 C) or higher
- Dry cough
- Shortness of breath
Related Conference of Severe Acute Respiratory Syndrome (SARS)
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Severe Acute Respiratory Syndrome (SARS) Conference Speakers
Recommended Sessions
- Pulmonary Rehabilitation
- Advances in Respiratory Medicine
- Asthma and Allergy
- Cardiopulmonary Sciences
- Chronic Obstructive Pulmonary Disease
- Lung Cancer Screening, Diagnosis & Treatment
- Lung Transplantation
- Pediatric Pulmonology & Critical care
- Pulmonary Hypertension
- Respiratory and Pulmonary Therapies
- Respiratory Tract Infections
- Severe Acute Respiratory Syndrome (SARS)
- Tuberculosis
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)